👍 Intercept Pharmaceuticals is an excellent company. Their website is impressive and provides all the required information. The customer service is top-notch. Keep up the good work!
Haven't used Intercept pharmaceuticals yet?
Ask AI
Ask AI about Intercept pharmaceuticals
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
10 Reviews
Disappointing customer service experience, website needs improvement. 🤔
I recently visited a pharmaceutical company's website. It was a pleasant experience as the website was user-friendly and provided comprehensive information. The only downside was the limited customer service options.
😊 Intercept Pharmaceuticals is an amazing company. Their website is user-friendly, and the customer service is outstanding. I highly recommend it!
I had a good experience with Intercept Pharmaceuticals. The website is informative and easy to navigate. Their customer service team was responsive and helpful. I would recommend their services.
Intercept Pharmaceuticals is an average company. Their website is user-friendly and informative. However, their customer service needs improvement. Overall, it's an okay experience.
👌 Intercept Pharmaceuticals has exceeded my expectations. Their website is comprehensive and easy to navigate. The customer service was excellent, and they promptly addressed my concerns.
Intercept Pharmaceuticals is a trustworthy company. Their website provides extensive information, and I had a pleasant experience navigating it. The customer service was helpful and professional.
I recently visited a pharmaceutical company's website. I found it to be quite helpful in providing the necessary information. The website was well-designed and easy to navigate. The only downside was the lack of customer service options.
Intercept Pharmaceuticals is a reliable company. Their website is informative and easy to use. I appreciated the professionalism of their customer service representatives. The overall experience was satisfactory.
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
or with email
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Intercept pharmaceuticals
We are INTERCEPT. Our mission is to build a healthier tomorrow for patients with progressive non-viral liver diseases.
Intercept Pharmaceuticals: Building a Healthier Tomorrow for Patients with Progressive Non-Viral Liver Diseases
Intercept Pharmaceuticals is a biopharmaceutical company that is dedicated to developing innovative treatments for patients with progressive non-viral liver diseases. The company was founded in 2002 and has since been at the forefront of research and development in this field.
At Intercept, our mission is to build a healthier tomorrow for patients suffering from liver diseases such as primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH), and other chronic liver diseases. We believe that by focusing on these areas, we can make a significant impact on the lives of millions of people around the world.
Our team consists of some of the most talented scientists, researchers, and medical professionals in the industry. We are committed to advancing our understanding of these complex diseases and developing new treatments that can improve patient outcomes.
One of our most significant achievements to date has been the development of Ocaliva® (obeticholic acid), which was approved by the U.S. Food and Drug Administration (FDA) in 2016 for use in patients with PBC. This breakthrough treatment has been shown to significantly improve liver function tests, reduce serum alkaline phosphatase levels, and alleviate symptoms associated with PBC.
In addition to Ocaliva®, we are also working on several other promising therapies that have shown great potential in clinical trials. These include INT-767, which targets both FXR and TGR5 receptors; INT-777, which targets only TGR5 receptors; and INT-1436, which targets both FXR receptors and bile acid transporters.
At Intercept Pharmaceuticals, we understand that there is still much work to be done when it comes to treating progressive non-viral liver diseases. That's why we are committed to continuing our research efforts until we find effective treatments for all patients who need them.
We also recognize that patient advocacy plays an essential role in achieving our goals. That's why we work closely with patient organizations such as The American Liver Foundation (ALF) and The Global Liver Institute (GLI) to raise awareness about these conditions among healthcare providers, policymakers, and the general public.
In conclusion,
Intercept Pharmaceuticals is a leading biopharmaceutical company dedicated to developing innovative treatments for patients suffering from progressive non-viral liver diseases such as PBC or NASH. Our team consists of some of the most talented scientists who are committed towards advancing their understanding about these complex disorders while developing new therapies aimed at improving patient outcomes.
Our breakthrough treatment Ocaliva® has already received FDA approval while several other promising therapies like INT-767 or INT-777 have shown great potential during clinical trials.
We remain steadfastly committed towards finding effective treatments until every single person suffering from these conditions receives proper care.
- Website
- interceptpharma.com
- [email protected]
- Categories
- Pharmaceuticals
